Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of circulating antibodies to tumor‐associated proteins for combined use as markers of non‐small cell lung cancer

23 Mar 2004

Abstract excerpt

Currently only a limited number of tumor markers for non-small cell lung cancer (NSCLC) are available. Antibodies to tumor-associated proteins may expand the number of available tumor markers for lung cancer and be used together in a serum profile to enhance sensitivity and specificity. In this study, we isolated 57 tumor-associated proteins from two NSCLC cDNA T7 phage libraries using biopan enrichment...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacteriophages and microbial interactions
Share to Glycosylation and Glycoproteins Research
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15049001
DOI: 10.1002/pmic.200200679

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of circulating antibodies to tumor‐associated proteins for combined use as markers of non‐small cell lung cancerPMID 15049001Read ↗

Using Protein Microarray as a Diagnostic Assay for Non–Small Cell Lung CancerSemantic proximity Read ↗

Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancerSemantic proximity Read ↗

Development of Natural Protein Microarrays for Diagnosing Cancer Based on an Antibody Response to Tumor AntigensSemantic proximity Read ↗

Identification and characterization of a suite of tumor targeting peptides for non-small cell lung cancer.Semantic proximity Read ↗

Integral Protein Microarrays for the Identification of Lung Cancer Antigens in Sera That Induce a Humoral Immune ResponseSemantic proximity Read ↗

Profiling Tumor-Associated Autoantibodies for the Detection of Colon CancerSemantic proximity Read ↗

Evaluation of T7 and lambda phage display systems for survey of autoantibody profiles in cancer patientsSemantic proximity Read ↗

New approaches for biomarker discovery in lung cancer.Semantic proximity Read ↗

Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phageSemantic proximity Read ↗

Detection of pancreatic cancer using antibody microarray‐based serum protein profilingSemantic proximity Read ↗

Identifying autoantibody signatures in cancer: a promising challengeSemantic proximity Read ↗

Seromic analysis of antibody responses in non-small cell lung cancer patients and healthy donors using conformational protein arraysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.